These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22581887)

  • 1. Cervical cytology screening in HIV-positive women: do samples from genitourinary medicine departments have high inadequacy rates?
    Sundaram SS; Vijeratnam D; Patel R; Samraj S
    Int J STD AIDS; 2012 Mar; 23(3):227. PubMed ID: 22581887
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cytology practice guideline. American Society of Cytopathology.
    Diagn Cytopathol; 2001 Jul; 25(1):3-24. PubMed ID: 11466809
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Liquid-based cytology for cervical screening.
    Blamey S; Jackson T; Robinson J
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):70-1; author reply 71-2. PubMed ID: 16441706
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal cytology as a screening tool for early detection of anal dysplasia in HIV-infected women.
    Gingelmaier A; Weissenbacher T; Kost B; Kaestner R; Sovric M; Mylonas I; Friese K; Bergauer F
    Anticancer Res; 2010 May; 30(5):1719-23. PubMed ID: 20592367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia.
    Thiryayi SA; Marshall J; Rana DN
    Cytopathology; 2010 Aug; 21(4):223-8. PubMed ID: 19843139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of diagnostic accuracy and screening conditions with liquid-based cytology.
    Schledermann D; Ejersbo D; Hoelund B
    Diagn Cytopathol; 2006 Nov; 34(11):780-5. PubMed ID: 17041948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid based cytology in cervical cancer screening.
    Denton KJ
    BMJ; 2007 Jul; 335(7609):1-2. PubMed ID: 17615183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspects in quality assurance in gynecological cytology].
    Hilgarth M
    Gynakologe; 1990 Dec; 23(6):312-8. PubMed ID: 2279705
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus and cervical cancer screening. Recent advances improve the clinical picture.
    Berman NR
    Adv Nurse Pract; 2002 Oct; 10(10):26-35; quiz 35-6. PubMed ID: 12424881
    [No Abstract]   [Full Text] [Related]  

  • 11. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European guidelines for quality assurance in cervical histopathology.
    Bulten J; Horvat R; Jordan J; Herbert A; Wiener H; Arbyn M
    Acta Oncol; 2011 Jun; 50(5):611-20. PubMed ID: 21314297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has cytology become obsolete as a primary test in screening for cervical cancer?
    Rebolj M; Lynge E
    J Med Screen; 2010; 17(1):1-2. PubMed ID: 20356936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peer comparison program for the quality assurance of human papillomavirus DNA detection using the Digene Hybrid Capture II/SurePath method shows excellent analytic interlaboratory correlation.
    Kuebler DL; Illingworth A; Blenc AM; Wilbur DC
    Cancer; 2007 Oct; 111(5):339-43. PubMed ID: 17879373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.
    Franceschi S; Jaffe H
    Clin Infect Dis; 2007 Aug; 45(4):510-3. PubMed ID: 17638204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.